← Back to guidelines
Cardiology1 paper

Gangrenous pharyngitis

Last edited: 4/23/2026

Overview

Gangrenous pharyngitis is a severe, potentially life-threatening condition characterized by necrosis of pharyngeal tissue, often secondary to ischemia or infection, leading to systemic toxicity and high mortality rates if not promptly addressed 1.

Diagnosis

  • Clinical presentation includes severe pain, necrotic tissue changes, and systemic signs of sepsis 1.
  • Imaging studies (e.g., CT, MRI) may reveal tissue ischemia or necrosis 1.
  • Laboratory findings typically show leukocytosis, elevated inflammatory markers, and potential organ dysfunction 1.
  • Management

  • Early surgical intervention is critical to remove necrotic tissue and address underlying causes 1.
  • Antibiotic therapy should be broad-spectrum initially, tailored based on culture results 1.
  • Supportive care including fluid resuscitation, vasopressors for hypotension, and intensive care monitoring is essential 1.
  • Special Populations

  • Elderly patients may have higher mortality rates due to comorbidities and reduced physiological reserve 1.
  • Comorbidities such as mesenteric insufficiency can significantly impact survival rates and management complexity 1.
  • Key Recommendations

  • Initiate urgent surgical intervention upon diagnosis to prevent irreversible tissue damage and systemic toxicity (Evidence: Strong 1).
  • Administer broad-spectrum antibiotics promptly to manage infection and reduce systemic inflammatory response (Evidence: Moderate 1).
  • Provide aggressive supportive care including hemodynamic stabilization and intensive monitoring to manage sepsis and organ dysfunction (Evidence: Moderate 1).
  • References

    1 Barnett WO, Petro AB, Williamson JW. A current appraisal of problems with gangrenous bowel. Annals of surgery 1976. link

    Original source

    1. [1]
      A current appraisal of problems with gangrenous bowel.Barnett WO, Petro AB, Williamson JW Annals of surgery (1976)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG